Skip to main content
. 2018 Sep 27;2(10):1213–1226. doi: 10.1002/hep4.1232

Figure 3.

Figure 3

Theoretical model of NR functions in the development of NASH. NR functions (in the presence of their respective ligands) are potentially protective against the development of NASH. Drugs targeting the pictured PPARδ, PPARγ, and FXRα receptors are in trials for the treatment of NASH and the metabolic syndrome. NR–NR heterodimers and interactions are not pictured. (Figure 3 was created by Dr. Nikita Consul, Columbia University College of Physicians and Surgeons, 2017). Abbreviations: ER, endoplasmic reticulum; ROS, reactive oxygen species.